Search Results 211-220 of 14777 for albumin

1. Cirrhosis - Diagnosis and treatment - Mayo Clinic

   This advanced stage of liver damage often shows no symptoms until it's quite serious. Find out about symptoms and treatment of this life-threatening liver ...

2. First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b - Mayo Clinic

   Albumin ≥ 3.0 g/dL. During the study, female study participants of child-bearing potential must use a highly effective non-hormonal form of contraception ...

3. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

   Albumin > 3 mg/dl; Blood urea nitrogen (BUN) =< 30 mg/dl; Creatinine =< 1.7 mg/dl; The following imaging workup to document metastases within 45 days prior to ...

4. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   Albumin ≥2.5 g/dL during screening; Serum creatinine ≤1.5 mg/dL during screening. Exclusion Criteria: Evidence of severe decompensation. Non-cirrhotic ...

5. A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment - Mayo Clinic

   Documented serum albumin < 3 g/dL. Known history of central nervous system (CNS) metastases. Clinically significant gastrointestinal disorder. History of ...

6. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Serum albumin >= 2 g/dL; Creatinine =< 1.5 times ULN for age OR a creatinine clearance or glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2; obtained ...

7. A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules in Patients With Advanced Solid Tumors - Mayo Clinic

   Albumin ≥ 3.0 g/dL. Acceptable renal function: Serum creatinine within normal limits, OR calculated creatinine clearance 60 mL/min/1.73 m^2 for patients ...

8. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Serum albumin < 3.5 g/dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

9. Amyloidosis - Symptoms and causes - Mayo Clinic

   This rare disease caused by a buildup of the protein amyloid can affect different organs in different people. Find out how early and accurate diagnosis can ...

10. A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer - Mayo Clinic

    Serum albumin ≥ 3.0 g/dL. Exclusion Criteria: Prior systemic treatment with androgen deprivation therapy and/or first-generation anti-androgen (e.g. ...